Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation

Kazue Someya, Hiroko Nakatsukasa, Minako Ito, Taisuke Kondo, Kenn ichi Tateda, Takashi Akanuma, Ikuko Koya, Tsukasa Sanosaka, Jun Kohyama, Yuichi Tsukada, Takeji Takamura-Enya, Akihiko Yoshimura

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Since induced regulatory T cells (iTregs) can be produced in a large quantity in vitro, these cells are expected to be clinically useful to induce immunological tolerance in various immunological diseases. Foxp3 (Forkhead box P3) expression in iTregs is, however, unstable due to the lack of demethylation of the CpG island in the conserved non-coding sequence 2 (CNS2) of the Foxp3 locus. To facilitate the demethylation of CNS2, we over-expressed the catalytic domain (CD) of the ten-eleven translocation (TET) protein, which catalyzes the steps of the iterative demethylation of 5-methylcytosine. TET-CD over-expression in iTregs resulted in partial demethylation of CNS2 and stable Foxp3 expression. We also discovered that TET expression was enhanced under low oxygen (5%) culture conditions, which facilitated CNS2 DNA demethylation and stabilization of Foxp3 expression in a TET2- and TET3-dependent manner. In combination with vitamin C treatment, which has been reported to enhance TET catalytic activity, iTregs generated under low oxygen conditions retained more stable Foxp3 expression in vitro and in vivo and exhibited stronger suppression activity in a colitis model compared with untreated iTregs. Our data indicate that the induction and activation of TET enzymes in iTregs would be an effective method for Treg-mediated adoptive immunotherapy.

Original languageEnglish
Article numberdxx049
Pages (from-to)365-375
Number of pages11
JournalInternational Immunology
Volume29
Issue number8
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Enzyme Induction
Enzyme Activation
Catalytic Domain
5-Methylcytosine
Oxygen
Adoptive Immunotherapy
CpG Islands
Immune System Diseases
Protein Transport
Regulatory T-Lymphocytes
Colitis
Ascorbic Acid
Enzymes
In Vitro Techniques
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Someya, K., Nakatsukasa, H., Ito, M., Kondo, T., Tateda, K. I., Akanuma, T., ... Yoshimura, A. (2017). Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. International Immunology, 29(8), 365-375. [dxx049]. https://doi.org/10.1093/intimm/dxx049

Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. / Someya, Kazue; Nakatsukasa, Hiroko; Ito, Minako; Kondo, Taisuke; Tateda, Kenn ichi; Akanuma, Takashi; Koya, Ikuko; Sanosaka, Tsukasa; Kohyama, Jun; Tsukada, Yuichi; Takamura-Enya, Takeji; Yoshimura, Akihiko.

In: International Immunology, Vol. 29, No. 8, dxx049, 01.08.2017, p. 365-375.

Research output: Contribution to journalArticle

Someya, K, Nakatsukasa, H, Ito, M, Kondo, T, Tateda, KI, Akanuma, T, Koya, I, Sanosaka, T, Kohyama, J, Tsukada, Y, Takamura-Enya, T & Yoshimura, A 2017, 'Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation', International Immunology, vol. 29, no. 8, dxx049, pp. 365-375. https://doi.org/10.1093/intimm/dxx049
Someya K, Nakatsukasa H, Ito M, Kondo T, Tateda KI, Akanuma T et al. Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. International Immunology. 2017 Aug 1;29(8):365-375. dxx049. https://doi.org/10.1093/intimm/dxx049
Someya, Kazue ; Nakatsukasa, Hiroko ; Ito, Minako ; Kondo, Taisuke ; Tateda, Kenn ichi ; Akanuma, Takashi ; Koya, Ikuko ; Sanosaka, Tsukasa ; Kohyama, Jun ; Tsukada, Yuichi ; Takamura-Enya, Takeji ; Yoshimura, Akihiko. / Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. In: International Immunology. 2017 ; Vol. 29, No. 8. pp. 365-375.
@article{0a48fe2dc32a41d7a256d923d3e04bbe,
title = "Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation",
abstract = "Since induced regulatory T cells (iTregs) can be produced in a large quantity in vitro, these cells are expected to be clinically useful to induce immunological tolerance in various immunological diseases. Foxp3 (Forkhead box P3) expression in iTregs is, however, unstable due to the lack of demethylation of the CpG island in the conserved non-coding sequence 2 (CNS2) of the Foxp3 locus. To facilitate the demethylation of CNS2, we over-expressed the catalytic domain (CD) of the ten-eleven translocation (TET) protein, which catalyzes the steps of the iterative demethylation of 5-methylcytosine. TET-CD over-expression in iTregs resulted in partial demethylation of CNS2 and stable Foxp3 expression. We also discovered that TET expression was enhanced under low oxygen (5{\%}) culture conditions, which facilitated CNS2 DNA demethylation and stabilization of Foxp3 expression in a TET2- and TET3-dependent manner. In combination with vitamin C treatment, which has been reported to enhance TET catalytic activity, iTregs generated under low oxygen conditions retained more stable Foxp3 expression in vitro and in vivo and exhibited stronger suppression activity in a colitis model compared with untreated iTregs. Our data indicate that the induction and activation of TET enzymes in iTregs would be an effective method for Treg-mediated adoptive immunotherapy.",
author = "Kazue Someya and Hiroko Nakatsukasa and Minako Ito and Taisuke Kondo and Tateda, {Kenn ichi} and Takashi Akanuma and Ikuko Koya and Tsukasa Sanosaka and Jun Kohyama and Yuichi Tsukada and Takeji Takamura-Enya and Akihiko Yoshimura",
year = "2017",
month = "8",
day = "1",
doi = "10.1093/intimm/dxx049",
language = "English",
volume = "29",
pages = "365--375",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation

AU - Someya, Kazue

AU - Nakatsukasa, Hiroko

AU - Ito, Minako

AU - Kondo, Taisuke

AU - Tateda, Kenn ichi

AU - Akanuma, Takashi

AU - Koya, Ikuko

AU - Sanosaka, Tsukasa

AU - Kohyama, Jun

AU - Tsukada, Yuichi

AU - Takamura-Enya, Takeji

AU - Yoshimura, Akihiko

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Since induced regulatory T cells (iTregs) can be produced in a large quantity in vitro, these cells are expected to be clinically useful to induce immunological tolerance in various immunological diseases. Foxp3 (Forkhead box P3) expression in iTregs is, however, unstable due to the lack of demethylation of the CpG island in the conserved non-coding sequence 2 (CNS2) of the Foxp3 locus. To facilitate the demethylation of CNS2, we over-expressed the catalytic domain (CD) of the ten-eleven translocation (TET) protein, which catalyzes the steps of the iterative demethylation of 5-methylcytosine. TET-CD over-expression in iTregs resulted in partial demethylation of CNS2 and stable Foxp3 expression. We also discovered that TET expression was enhanced under low oxygen (5%) culture conditions, which facilitated CNS2 DNA demethylation and stabilization of Foxp3 expression in a TET2- and TET3-dependent manner. In combination with vitamin C treatment, which has been reported to enhance TET catalytic activity, iTregs generated under low oxygen conditions retained more stable Foxp3 expression in vitro and in vivo and exhibited stronger suppression activity in a colitis model compared with untreated iTregs. Our data indicate that the induction and activation of TET enzymes in iTregs would be an effective method for Treg-mediated adoptive immunotherapy.

AB - Since induced regulatory T cells (iTregs) can be produced in a large quantity in vitro, these cells are expected to be clinically useful to induce immunological tolerance in various immunological diseases. Foxp3 (Forkhead box P3) expression in iTregs is, however, unstable due to the lack of demethylation of the CpG island in the conserved non-coding sequence 2 (CNS2) of the Foxp3 locus. To facilitate the demethylation of CNS2, we over-expressed the catalytic domain (CD) of the ten-eleven translocation (TET) protein, which catalyzes the steps of the iterative demethylation of 5-methylcytosine. TET-CD over-expression in iTregs resulted in partial demethylation of CNS2 and stable Foxp3 expression. We also discovered that TET expression was enhanced under low oxygen (5%) culture conditions, which facilitated CNS2 DNA demethylation and stabilization of Foxp3 expression in a TET2- and TET3-dependent manner. In combination with vitamin C treatment, which has been reported to enhance TET catalytic activity, iTregs generated under low oxygen conditions retained more stable Foxp3 expression in vitro and in vivo and exhibited stronger suppression activity in a colitis model compared with untreated iTregs. Our data indicate that the induction and activation of TET enzymes in iTregs would be an effective method for Treg-mediated adoptive immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85032872960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032872960&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxx049

DO - 10.1093/intimm/dxx049

M3 - Article

VL - 29

SP - 365

EP - 375

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 8

M1 - dxx049

ER -